None listed
Conditions
Brief summary
Despite a dramatic decline in tobacco smoking prevalence, current smoking rates have plateaued and smoking remains the leading cause of preventable diseases and death in Australia. Smoking rates in ICU patients are higher than the general population, offering an opportunity for intervention, especially as there is good evidence that many smokers do consider cessation following an ICU admission. Thus surviving an ICU admission potentially provides a unique opportunity to promote long-term smoking cessation. Whilst smoking cessation interventions have been evaluated in hospital settings, the optimal intervention remains unclear and no studies looking at combination nicotine replacement therapy (NRT) and counselling have been performed specifically in ICU survivors. Our goal is to conduct a randomized controlled trial comparing standard care (ad hoc advice to patients and NRT) to a formal brief counselling intervention in addition to protocolized NRT. The aim is to improve smoking cessation rates in ICU survivors and thus improve their morbidity and mortality.
Interventions
Nicotine replacement therapy (patch 21mg) replaced daily, until discharge from hospital. Medication adherence will be monitored using hospital medication chart. + Brief Intervention - A formal brief counselling intervention consisting of a one-off session discussing smoking cessation strategies following the GP QUIT advice program. Session will be one-off 15-30 minute session at time of readiness for ICU discharge. Intervention administered by a member of the research team. Smoking cessation strategies follow the Ask, Advice, Help model, and how patients can refer themselves to QUIT, and how nicotine replacment therapy can assist with withdrawal symptoms.
Sponsors
Study design
Eligibility
Inclusion criteria
Patients who are admitted to the intensive care unit and are active tobacco smokers that smoke >10 cigarettes per day .
Exclusion criteria
Exclude patients less than 18 years of age, who are pregnant or lactating, hypersensitivity to nicotine or transdermal patches, or who are not expected to survive > 48 hours. Not able to consent or non-English speaking.